ITRM920693A0 - Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi. - Google Patents

Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.

Info

Publication number
ITRM920693A0
ITRM920693A0 IT92RM693A ITRM920693A ITRM920693A0 IT RM920693 A0 ITRM920693 A0 IT RM920693A0 IT 92RM693 A IT92RM693 A IT 92RM693A IT RM920693 A ITRM920693 A IT RM920693A IT RM920693 A0 ITRM920693 A0 IT RM920693A0
Authority
IT
Italy
Prior art keywords
carnitine
patients
acil
aids
treatment
Prior art date
Application number
IT92RM693A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM920693A0 publication Critical patent/ITRM920693A0/it
Priority to ITRM920693A priority Critical patent/IT1258491B/it
Priority to ZA936300A priority patent/ZA936300B/xx
Priority to DK93114235.0T priority patent/DK0590355T3/da
Priority to AT93114235T priority patent/ATE160090T1/de
Priority to EP93114235A priority patent/EP0590355B1/en
Priority to ES93114235T priority patent/ES2110551T3/es
Priority to DE69315162T priority patent/DE69315162T2/de
Priority to KR1019930018520A priority patent/KR0136559B1/ko
Priority to JP5237790A priority patent/JPH06227983A/ja
Publication of ITRM920693A1 publication Critical patent/ITRM920693A1/it
Priority to US08/370,357 priority patent/US5631288A/en
Application granted granted Critical
Publication of IT1258491B publication Critical patent/IT1258491B/it
Priority to GR970402512T priority patent/GR3025372T3/el
Priority to HK98104022.7A priority patent/HK1004910B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
ITRM920693A 1992-09-24 1992-09-24 Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi. IT1258491B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITRM920693A IT1258491B (it) 1992-09-24 1992-09-24 Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.
ZA936300A ZA936300B (en) 1992-09-24 1993-08-27 Use of L-carnitine and acyl L-carnitines for treating patients suffering from AIDS and AIDS-related syndromes and asymptomatic HIV-seropositive patients
DE69315162T DE69315162T2 (de) 1992-09-24 1993-09-06 Verwendung von L-Carnitine und Acyl-L-Carnitinen zur Behandlung von Patienten die an AIDS-verwandten Syndromen leiden und von asymptomatischen HIV-seropositiven Patienten
AT93114235T ATE160090T1 (de) 1992-09-24 1993-09-06 Verwendung von l-carnitine und acyl-l-carnitinen zur behandlung von patienten die an aids- verwandten syndromen leiden und von asymptomatischen hiv-seropositiven patienten
EP93114235A EP0590355B1 (en) 1992-09-24 1993-09-06 Use of L-carnitine and acyl L-carnitines for treating patients suffering from aids-related syndromes and asymptomatic HIV-seropositive patients
ES93114235T ES2110551T3 (es) 1992-09-24 1993-09-06 Empleo de l-carnitina y acil l-carnitinas para tratamiento de pacientes que padecen sindromes relacionados con el sida y pacientes de hiv seropositivos asintomaticos.
DK93114235.0T DK0590355T3 (da) 1992-09-24 1993-09-06 Anvendelse af L-carnitin og acyl-L-carnitiner til behandling af patienter, der lider af AIDS-relaterede syndromer og asymptomatiske HIV-seropositive patienter
KR1019930018520A KR0136559B1 (ko) 1992-09-24 1993-09-13 에이즈 및 에이즈 관련 증후군 환자 및 무증후성 hiv 혈청양성 환자 치료를 위한 l-카르니틴 및 아실 l-카르니틴의 용도
JP5237790A JPH06227983A (ja) 1992-09-24 1993-09-24 エイズ治療のためのｌ−カルニチン類の使用
US08/370,357 US5631288A (en) 1992-09-24 1995-01-09 Therapeutic method of treating patients suffering from AIDS and AIDS-related syndromes and asymptomatic HIV-seropositive patients.
GR970402512T GR3025372T3 (en) 1992-09-24 1997-11-13 Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients
HK98104022.7A HK1004910B (en) 1992-09-24 1998-05-09 Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920693A IT1258491B (it) 1992-09-24 1992-09-24 Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.

Publications (3)

Publication Number Publication Date
ITRM920693A0 true ITRM920693A0 (it) 1992-09-24
ITRM920693A1 ITRM920693A1 (it) 1994-03-24
IT1258491B IT1258491B (it) 1996-02-26

Family

ID=11401203

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920693A IT1258491B (it) 1992-09-24 1992-09-24 Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.

Country Status (11)

Country Link
US (1) US5631288A (it)
EP (1) EP0590355B1 (it)
JP (1) JPH06227983A (it)
KR (1) KR0136559B1 (it)
AT (1) ATE160090T1 (it)
DE (1) DE69315162T2 (it)
DK (1) DK0590355T3 (it)
ES (1) ES2110551T3 (it)
GR (1) GR3025372T3 (it)
IT (1) IT1258491B (it)
ZA (1) ZA936300B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6922994A (en) * 1993-06-21 1995-01-17 Bernardini, Attilio Use of acylcarnitin to treat illnesses caused by aids
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US20080119386A1 (en) * 2006-11-22 2008-05-22 Carl Germano Nutritional formula for athletes' recovery
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) * 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1143214B (it) * 1981-07-09 1986-10-22 Sigma Tau Ind Farmaceuti Acil derivato della carnitina quale immunomodulatore
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease

Also Published As

Publication number Publication date
KR940006576A (ko) 1994-04-25
ITRM920693A1 (it) 1994-03-24
EP0590355A1 (en) 1994-04-06
DE69315162T2 (de) 1998-03-12
HK1004910A1 (en) 1998-12-11
EP0590355B1 (en) 1997-11-12
DK0590355T3 (da) 1998-03-02
GR3025372T3 (en) 1998-02-27
ZA936300B (en) 1995-02-27
KR0136559B1 (ko) 1998-04-25
ES2110551T3 (es) 1998-02-16
US5631288A (en) 1997-05-20
ATE160090T1 (de) 1997-11-15
IT1258491B (it) 1996-02-26
JPH06227983A (ja) 1994-08-16
DE69315162D1 (de) 1997-12-18

Similar Documents

Publication Publication Date Title
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
DK0978276T3 (da) Polymerovertrukken tablet omfattende amoxycillin og clavulanat
FI970920L (fi) Trifenyylietyleenejä käytettäväksi osteoporoosin ehkäisyyn ja hoitoon
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
FI931183A7 (fi) Puolijohdekondensaattori ja mikrofonilaite
EP0790826A4 (en) DYHYDROPYRIMIDINE AND THEIR USE
DK0745396T3 (da) Blodpumpe og anvendelse deraf
ITRM920270A0 (it) Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
EP0833914A4 (en) BETA-11 HUMAN CHEMOKINE AND ALPHA-1 HUMAN CHEMOKINE
DE69512853D1 (de) Bilderzeugungsverfahren und -Vorrichtungen
DK0837686T3 (da) Anvendelse af ufordøjelige oligosaccharider til behandling og forebyggelse af mellemørebetændelse i mennesker
EP0811059A4 (en) HUMAN CHEMOKINE BETA-11 AND ALPHA-1
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
BR9501946A (pt) Poliuretano-poliuréias hidrófilas e sua aplicação
ZA935575B (en) Therapeutic agent and its use.
PT983271E (pt) Hemissulfato carbociclico nucleosidico e a sua utilizacao no tratamento de infeccoes virais
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
ITMI940282A0 (it) Procedimento e dispositivo per la depurazione di sostanze sgrassanti
DK116692D0 (da) Method for the securing of an electro-acoustic device and electro-acoustic device for use in the method
NL1007839A1 (nl) Formulering en gebruik.
ITRM910796A0 (it) Impiego di l-carnitina e acil l-carnitine nel trattamento delle oligoastenospermie idiopatiche
ITTO940392A0 (it) Procedimento e dispositivo per la microfinitura di ruote dentate.
EP0893123A4 (en) MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970709